Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enbrel for Fatigue and Cachexia in Advanced Cancer Patients Receiving Radiation Therapy
NCT00127387Phase 3Terminated
- Sponsor
- UT Health San Antonio
- Start
- May 2001
- Primary completion
- Sep 2005
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in fatigue and cachexia comparing Enbrel with Placebo (2 arms). Primary endpoint: Quality of Life. Started May 2001; status: terminated.
02
Drugs
etanercept
03
Conditions
fatiguecachexia
Beyond the preview
Go deeper on NCT00127387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00127387.